Alerts will be sent to your verified email
Verify Email
ACCENTMIC
|
Accent Microcell
|
Kilitch Drugs(India)
|
Fredun Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
19.77 % | 4.81 % | 8.53 % |
|
5yr average Equity Multiplier
|
2.38 | 1.42 | 3.02 |
|
5yr Average Asset Turnover Ratio
|
1.57 | 0.51 | 1.01 |
|
5yr Avg Net Profit Margin
|
6.42 % | 6.07 % | 2.89 % |
|
Price to Book
|
0.0 | 3.07 | 4.1 |
|
P/E
|
19.46 | 22.2 | 24.75 |
|
5yr Avg Cash Conversion Cycle
|
50.97 Days | -7.56 Days | 137.13 Days |
|
Inventory Days
|
74.08 Days | 17.9 Days | 140.46 Days |
|
Days Receivable
|
62.56 Days | 138.92 Days | 52.11 Days |
|
Days Payable
|
79.61 Days | 199.26 Days | 131.93 Days |
|
5yr Average Interest Coverage Ratio
|
11.5 | 5.07 | 2.31 |
|
5yr Avg ROCE
|
25.04 % | 8.16 % | 16.75 % |
|
5yr Avg Operating Profit Margin
|
10.39 % | 9.07 % | 8.32 % |
|
5 yr average Debt to Equity
|
0.61 | 0.14 | 0.86 |
|
5yr CAGR Net Profit
|
44.43 % | 77.02 % | 52.4 % |
|
5yr Average Return on Assets
|
9.28 % | 3.38 % | 3.05 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
55.09 % | 69.23 % | 48.93 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.98 % | -2.11 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Accent Microcell
|
Kilitch Drugs(India)
|
Fredun Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|